Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
One panel member abstained from voting
In March 2024, the FDA further approved Wegovy to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke) in adults with established cardiovascular disease and either obesity or overweight
Ongoing Support: You have 24/7 access to a dedicated team to answer questions about side effects, dosing, and lifestyle changes
Melanotan II is the one getting the most attention, but any peptide marketed for cosmetic tanning falls into the same category: unapproved, unregulated, and untested for long-term safety in healthy skin
